Verrica Pharmaceuticals (VRCA) Operating Leases (2021 - 2025)
Historic Operating Leases for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to $665000.0.
- Verrica Pharmaceuticals' Operating Leases changed 0.0% to $665000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $665000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $583000.0 for FY2024, which is 3593.41% down from last year.
- Per Verrica Pharmaceuticals' latest filing, its Operating Leases stood at $665000.0 for Q3 2025, which was down 0.0% from $416000.0 recorded in Q2 2025.
- In the past 5 years, Verrica Pharmaceuticals' Operating Leases ranged from a high of $1.6 million in Q1 2021 and a low of $416000.0 during Q2 2025
- In the last 5 years, Verrica Pharmaceuticals' Operating Leases had a median value of $1.1 million in 2023 and averaged $1.1 million.
- Data for Verrica Pharmaceuticals' Operating Leases shows a peak YoY increase of 0.0% (in 2025) and a maximum YoY decrease of 4408.6% (in 2025) over the last 5 years.
- Over the past 5 years, Verrica Pharmaceuticals' Operating Leases (Quarter) stood at $1.4 million in 2021, then decreased by 15.18% to $1.2 million in 2022, then decreased by 25.96% to $910000.0 in 2023, then tumbled by 35.93% to $583000.0 in 2024, then increased by 14.07% to $665000.0 in 2025.
- Its Operating Leases was $665000.0 in Q3 2025, compared to $416000.0 in Q2 2025 and $500000.0 in Q1 2025.